Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

AMS (American Medical Systems) prices convertible debt offering:

This article was originally published in Clinica

Executive Summary

American Medical Systems (AMS) last week priced $325m worth of convertible senior subordinated notes that will mature in 2036. The notes will be convertible either into cash or AMS shares, depending on the circumstances, said the Minneapolis, Minnesota company. The firm plans to use the net proceeds from the offering to fund part of its proposed $715m purchase of San Jose, California-based Laserscope (see Clinica No 1209, p 16), as well as for general working capital purposes. Should the Laserscope transaction fall through, AMS said it would use the proceeds for other possible acquisitions.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT052124

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel